Moody Aldrich Partners LLC increased its position in shares of Amsurg Corp. (NASDAQ:AMSG) by 116.5% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 8,615 shares of the company’s stock after buying an additional 4,635 shares during the period. Moody Aldrich Partners LLC’s holdings in Amsurg Corp. were worth $668,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AMSG. Boston Advisors LLC bought a new position in Amsurg Corp. during the second quarter worth about $930,000. Smith Asset Management Group LP raised its position in Amsurg Corp. by 8,500.0% in the second quarter. Smith Asset Management Group LP now owns 1,720 shares of the company’s stock worth $133,000 after buying an additional 1,700 shares during the period. Stoneridge Investment Partners LLC bought a new position in Amsurg Corp. during the second quarter worth about $572,000. Bank of Montreal Can bought a new position in Amsurg Corp. during the second quarter worth about $36,148,000. Finally, Adams Diversified Equity Fund Inc. bought a new position in Amsurg Corp. during the second quarter worth about $395,000. Hedge funds and other institutional investors own 98.42% of the company’s stock.
Amsurg Corp. (NASDAQ:AMSG) traded down 0.42% during mid-day trading on Monday, hitting $64.51. The stock had a trading volume of 1,059,108 shares. The company has a 50 day moving average price of $65.56 and a 200 day moving average price of $73.65. The stock has a market cap of $3.47 billion, a P/E ratio of 19.14 and a beta of 0.65. Amsurg Corp. has a one year low of $58.37 and a one year high of $87.29.
Amsurg Corp. (NASDAQ:AMSG) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $1.10 EPS for the quarter, topping the consensus estimate of $1.08 by $0.02. Amsurg Corp. had a net margin of 6.53% and a return on equity of 8.20%. The business had revenue of $758.50 million for the quarter, compared to analysts’ expectations of $769.88 million. During the same quarter last year, the company posted $0.97 earnings per share. The company’s quarterly revenue was up 21.5% compared to the same quarter last year. On average, equities analysts anticipate that Amsurg Corp. will post $4.33 EPS for the current year.
A number of research firms recently issued reports on AMSG. Citigroup Inc. began coverage on Amsurg Corp. in a report on Monday. They issued a “buy” rating and a $79.00 target price for the company. Zacks Investment Research lowered Amsurg Corp. from a “buy” rating to a “hold” rating in a report on Friday, August 5th. Cantor Fitzgerald reiterated a “buy” rating and issued a $95.00 target price on shares of Amsurg Corp. in a report on Thursday, July 14th. Jefferies Group reiterated a “buy” rating on shares of Amsurg Corp. in a report on Sunday, July 3rd. Finally, Mizuho lifted their target price on Amsurg Corp. from $90.00 to $95.00 and gave the company a “buy” rating in a report on Friday, June 24th. Three research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $92.55.
In other news, insider Robert Jon Coward sold 7,500 shares of the stock in a transaction dated Thursday, August 18th. The shares were sold at an average price of $64.36, for a total transaction of $482,700.00. Following the transaction, the insider now owns 105,007 shares of the company’s stock, valued at $6,758,250.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 2.30% of the company’s stock.
Amsurg Corp. Company Profile
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Want to see what other hedge funds are holding AMSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amsurg Corp. (NASDAQ:AMSG).
Receive News & Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related companies with MarketBeat.com's FREE daily email newsletter.